Mammotome | Advancing Breast Biopsy Technology
physicians
+ Procedures
"I chose to use the 8G Mammotome® ST because it is a fast and efficient tool for complete or partial removal of imaged evidence of the lesion. In addition, the size and integrity of the 8G samples offer simple and immediate confirmation that I am sampling the correct area in question." -Terri-Ann Gizienski, M.D.

The Original Mammotome® Breast Biopsy System

As the world-wide leader in vacuum-assisted breast biopsy and tissue marking, Mammotome is committed to advancing technology for early detection of breast cancer.

The Mammotome® Biopsy System was the first vacuum-assisted biopsy device on the market, and is also the most clinically acclaimed. The key clinical proof is the more than 4 million patients who have undergone a biopsy with the Mammotome® biopsy system, and the 280+ clinical articles published on its efficacy. Our system empowers physicians to offer a more accurate diagnosis without the complications of an open surgical biopsy; maximizes tissue quality and diagnosis accuracy; and keeps up with the changing needs of physicians and patients with a software-driven and upgradeable system.

legacy legacy

CM
SmartVac

Mammotome's breakthrough computer-controlled vacuum system that keeps openings in the aperture and vacuum lines clear, virtually eliminating "dry taps".

CM
Single Insertion

Use of a single incision, single insertion, and single probe makes the Mammotome® Biopsy System a reliable diagnostic alternative to open surgical biopsy.

The Mammotome® Biopsy System enables biopsies to be performed less invasively under multiple platforms utilizing the same control module:

+ Original Mammotome® ST Stereotactic (x-ray) Imaging

+ Original Mammotome® EX Ultrasound Imaging

+ Original Mammotome® MR Magnetic Resonance Imaging (MRI)

+ Original Mammotome® MI for Molecular Imaging (MI)